14 smaller drug makers’ earnings halves in 1Q

Influenced by the government’s intensive campaign to prevent illegal kickbacks, 14 smaller companies with less than 100 billion won in sales saw their earnings shrink almost 50 percent in the first three months of fiscal 2012, the data revealed on Monday.

These companies include Kyungdong Pharma, Bukwang Pharma, Yungjin Pharma, Hyundai Pharma, Whanin Pharma, Dongsung Pharma, Hwail Pharma, Sa...